v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Statement of Comprehensive Income [Abstract]        
Operating income $ 1.6 $ 2.8 $ 3.1 $ 5.0
Operating expenses        
Research and development expenses (47.0) (28.6) (111.6) (83.8)
Sales and marketing expenses (5.3) (1.2) (15.7) (1.9)
General and administrative expenses (14.0) (7.3) (39.1) (21.3)
Total Operating expenses (66.3) (37.1) (166.4) (107.0)
Loss from operations (64.8) (34.3) (163.3) (102.0)
Financial income (expense) 0.6 1.1 1.5 0.0
Loss before taxes (64.2) (33.2) (161.7) (102.0)
Income tax (0.3) 0.0 (0.7) (0.1)
Net loss (64.5) (33.2) (162.5) (102.1)
Foreign currency translation differences, net of taxes (0.3) (0.5) (5.5) 7.4
Actuarial gains or losses on employee benefits, net of taxes 0.1 (0.4) 0.1 (0.4)
Comprehensive loss $ (64.6) $ (34.0) $ (167.9) $ (95.1)
Basic net loss per share attributable to shareholders (in dollars per share) $ (0.14) $ (0.24) $ (0.37) $ (0.82)
Diluted net loss per share attributable to shareholders (in dollars per share) $ (0.14) $ (0.24) $ (0.37) $ (0.82)
Weighted average shares outstanding used in computing per share amounts, basic (in shares) 451,026,667 136,811,952 433,484,635 124,723,638
Weighted average shares outstanding used in computing per share amounts, diluted (in shares) 451,026,667 136,811,952 433,484,635 124,723,638